Joseph P. Lyssikatos
Chief Scientific Officer at Enliven Therapeutics Inc.
Sits on 1 board. Last updated September 27, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Enliven Therapeutics Inc., 3 years.
Enliven Therapeutics Inc.
Director · CHIEF SCIENTIFIC OFFICER
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 12, 2026 | Enliven Therapeutics Inc. | Grant or award | +18,750 | — | — |
| Feb 6, 2026 | Enliven Therapeutics Inc. | Open-market sale | −5,000 | $29.04 | $145,200 |
| Jan 20, 2026 | Enliven Therapeutics Inc. | Open-market sale | −5,491 | $26.37 | $144,798 |
| Jan 20, 2026 | Enliven Therapeutics Inc. | Open-market sale | −14,509 | $26.90 | $390,292 |
| Jan 9, 2026 | Enliven Therapeutics Inc. | Open-market sale | −41,198 | $24.90 | $1,025,830 |
| Jan 9, 2026 | Enliven Therapeutics Inc. | Open-market sale | −50,000 | $29.13 | $1,456,500 |
| Jan 8, 2026 | Enliven Therapeutics Inc. | Open-market sale | −7,500 | $20.13 | $150,975 |
| Jan 8, 2026 | Enliven Therapeutics Inc. | Open-market sale | −33,802 | $24.92 | $842,346 |
| Dec 19, 2025 | Enliven Therapeutics Inc. | Open-market sale | −5,000 | $16.84 | $84,200 |
| Nov 19, 2025 | Enliven Therapeutics Inc. | Open-market sale | −12,008 | $22.30 | $267,778 |
| Nov 19, 2025 | Enliven Therapeutics Inc. | Open-market sale | −492 | $23.09 | $11,360 |
| Oct 20, 2025 | Enliven Therapeutics Inc. | Open-market sale | −12,500 | $22.08 | $276,000 |
| Sep 26, 2025 | Enliven Therapeutics Inc. | Open-market sale | −4,000 | $20.25 | $81,000 |
| Sep 23, 2025 | Enliven Therapeutics Inc. | Open-market sale | −1,500 | $20.03 | $30,045 |
| Sep 19, 2025 | Enliven Therapeutics Inc. | Open-market sale | −4,870 | $19.11 | $93,066 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.